UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010582
Receipt No. R000012367
Scientific Title Multicenter phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320)
Date of disclosure of the study information 2013/04/26
Last modified on 2019/04/24 09:25:58

No. Disposal Last modified on Item of update
1 Insert 2013/04/24 13:45:41
2 Update 2013/10/24 09:59:51 Email
Email
3 Update 2014/05/26 10:31:54 Email1
4 Update 2014/07/18 10:40:34 Email
5 Update 2015/04/27 15:06:38 Public title
Public title
Acronym
Acronym
6 Update 2015/04/27 15:08:08 Narrative objectives1
Narrative objectives1
7 Update 2015/04/27 15:16:39 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
8 Update 2016/04/25 08:57:53 Name of primary sponsor
Organization
9 Update 2016/04/25 09:27:22 Control
Interventions/Control_1
Interventions/Control_1
10 Update 2016/08/16 10:03:52 Recruitment status
Last follow-up date
11 Update 2018/05/17 09:25:09 Date analysis concluded
12 Update 2019/04/24 09:25:58 Recruitment status
Date of IRB
Anticipated trial start date


Contact us.